Zandelisib On Intermittent Dosing As A Single Agent Or In Combination With Rituximab Or Zanubrutinib In Relapsed/Refractory (R/R) Follicular Lymphoma (Fl): Results From A Multi-Arm Phase 1B Study
Zandelisib;Rituximab;Zanubrutinib
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Zandelisib On Intermittent Dosing As A Single Agent Or In Combination With Rituximab Or Zanubrutinib In Relapsed/Refractory (R/R) Follicular Lymphoma (Fl): Results From A Multi-Arm Phase 1B Study ### Output: Zandelisib;Rituximab;Zanubrutinib